Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...
Dermatologists explain how hypochlorous acid can treat redness and acne, and suggest some more products that use it.
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces it has entered into a definitive asset purchase agreement (the "Agreement") with PRN Physician Recommended ...
As the monsoon season arrives, bringing much-needed relief from the heat, it also ushers in a host of potential health issues ...
In an intriguing turn of events, NovaBay Pharmaceuticals, Inc. (NYSE: NBY) has captured market attention with a remarkable surge of 50.97%, reaching $0.7502 during the Friday trading session at 11:17 ...
After hours: September 20 at 5:39 PM EDT Loading Chart for TARS ...